The Latest Cardiac and Vascular News
PARIS and NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, announces the enrollment of the first patient in its QUORUM […]
GETINGE, Sweden, June 5, 2019 /PRNewswire/ — Getinge has opened up a brand new acute care section focused on Cardiovascular Procedures in one of its Experience Centers located in Rastatt, Germany. Here, customers have the possibility to learn more about the solutions that Getinge provides to not only aid in the Coronary Artery Bypass Surgery […]
CAESAREA, Israel, June 04, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused […]
FLAGSTAFF, Ariz., June 4, 2019 /PRNewswire/ — W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ostium secundum atrial septal defects (ASDs). The FDA approval was supported by data collected from the pivotal stage of the Gore […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the first patient was enrolled in a U.S. early feasibility study evaluating the AccuCinch® Ventricular Repair System as a treatment for patients with reduced ejection fraction systolic heart failure (HFrEF). The first patient […]
First-in-Human Data for MYK-491 in Healthy Volunteers Demonstrated Well-Tolerated Increases in Cardiac Contractility Topline Results from Phase 2a Clinical Trial of MYK-491 in Patients with Stable Heart Failure with Reduced Ejection Fraction Anticipated in Second Half 2019 SOUTH SAN FRANCISCO, Calif. and ATHENS, Greece, May 28, 2019 (GLOBE NEWSWIRE) — […]
NETANYA, Israel, May 28, 2019 /PRNewswire/ — Sensible Medical Innovations and Bayer successfully signed an agreement making Bayer, Sensible’s largest customer in Europe. Bayer will use Sensible ReDS™ technology as an exploratory device-derived biomarker to monitor lung congestion in a clinical trial (ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03901729). The ReDS System is a wearable vest which quantifies the amount of […]
MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular™, a pioneering medical device company focused on improving outcomes for patients suffering from Acute Decompensated Heart Failure (ADHF), today announced the results of two non-randomized, prospective clinical trials in patients hospitalized with Acute Heart Failure (AHF). The two studies demonstrate that using Reprieve-Guided Diuretic Therapy, the […]
PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced positive results from a study of the company’s Helix™ Biotherapeutic Delivery System for cell therapy used to treat patients early following acute myocardial infarction (AMI) […]
MILPITAS, Calif. & PARIS–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced at EuroPCR excellent 9 and 12-month clinical and imaging data for the DynamX™ Novolimus-eluting Bioadaptor System, a next-generation coronary intervention system designed to treat blocked arteries via a novel vessel […]
